A trade group representing the pharmaceutical research and biopharmaceutical companies
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORBES-TATE | 52 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 52 |
| Health Issues | 52 |
| Medicare/Medicaid | 52 |
| Consumer Issues/Safety/Products | 31 |
| Trade (domestic/foreign) | 27 |
| Budget/Appropriations | 5 |
| Defense | 3 |
| Medical/Disease Research/Clinical Labs | 1 |